|
68
|
230
|
4qwjM |
Ycp beta5-a49t-mutant in complex with carfilzomib |
|
64
|
231
|
4qwfE |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
59
|
196
|
4qvmN |
Ycp beta5-m45a mutant in complex with bortezomib |
|
58
|
222
|
4qw7H |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
65
|
231
|
4qv6E |
Ycp beta5-a49v mutant |
|
60
|
196
|
4qlsN |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
66
|
244
|
4qzwB |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
60
|
222
|
4qwxL |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
243
|
4qlsF |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
66
|
231
|
4qw7E |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
72
|
244
|
4quxB |
Ycp beta5-a49t-mutant |
|
68
|
233
|
4r02M |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
70
|
240
|
4qvnC |
Ycp beta5-m45v mutant in complex with bortezomib |
|
57
|
233
|
4r67B |
Human constitutive 20s proteasome in complex with carfilzomib |
|
61
|
195
|
4qz2J |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
231
|
4qwkE |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
73
|
240
|
4qvvC |
Ycp beta5-a49v mutant in complex with bortezomib |
|
63
|
231
|
4qv3E |
Ycp beta5-m45v mutant |
|
66
|
212
|
4qwuK |
Ycp beta5-c52f mutant in complex with bortezomib |
|
66
|
242
|
4qw5D |
Ycp beta5-m45a mutant in complex with carfilzomib |
|
70
|
243
|
4qv8F |
Ycp beta5-c52f mutant |
|
63
|
241
|
4qzwG |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
60
|
195
|
4qwuJ |
Ycp beta5-c52f mutant in complex with bortezomib |
|
67
|
244
|
4qw4B |
Ycp in complex with carfilzomib |
|
56
|
204
|
4qvqI |
Ycp beta5-m45i mutant in complex with bortezomib |
|
69
|
242
|
4qlsD |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
65
|
244
|
4r02B |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
62
|
241
|
4qxjG |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qw0L |
Ycp beta5-a49t-a50v-double mutant in complex with bortezomib |
|
58
|
222
|
4qvqL |
Ycp beta5-m45i mutant in complex with bortezomib |
|
71
|
244
|
4qv1B |
Ycp beta5-m45a mutant |
|
69
|
233
|
4qzzM |
Ycp in complex with omuralide |
|
68
|
244
|
4qz4B |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
226
|
4qvnH |
Ycp beta5-m45v mutant in complex with bortezomib |
|
70
|
243
|
4qv4F |
Ycp beta5-m45t mutant |
|
57
|
195
|
4qbyJ |
Ycp in complex with boc-ala-ala-ala-cho |
|
72
|
244
|
4q1sF |
Yeast 20s proteasome in complex with kendomycin |
|
71
|
212
|
4q1sK |
Yeast 20s proteasome in complex with kendomycin |
|
70
|
242
|
4q1sD |
Yeast 20s proteasome in complex with kendomycin |
|
26
|
131
|
4pv3B |
Crystal structure of potassium-dependent plant-type l-asparaginase from phaseolus vulgaris in complex with na+ cations |
|
73
|
250
|
4qbyA |
Ycp in complex with boc-ala-ala-ala-cho |
|
156
|
557
|
4pelB |
S1c mutant of penicillin g acylase from kluyvera citrophila |
|
60
|
226
|
4qbyH |
Ycp in complex with boc-ala-ala-ala-cho |
|
67
|
240
|
4qbyC |
Ycp in complex with boc-ala-ala-ala-cho |
|
61
|
196
|
4q1sN |
Yeast 20s proteasome in complex with kendomycin |
|
24
|
131
|
4pv2B |
Crystal structure of potassium-dependent plant-type l-asparaginase from phaseolus vulgaris in complex with k+ and na+ cations |
|
61
|
231
|
4qbyE |
Ycp in complex with boc-ala-ala-ala-cho |
|
57
|
204
|
4qbyI |
Ycp in complex with boc-ala-ala-ala-cho |
|
69
|
250
|
4q1sA |
Yeast 20s proteasome in complex with kendomycin |
|
148
|
559
|
4pemB |
Crystal structure of s1g mutant of penicillin g acylase from kluyvera citrophila |
